Standard Biotools (LAB) Cash from Financing Activities (2010 - 2026)
Standard Biotools (LAB) reported Cash from Financing Activities of -$40000.0 for Q1 2026, up 13.04% year-over-year from -$35384.6 in Q1 2025, and down 106.45% quarter-over-quarter from $620000.0 in Q4 2025.
Standard Biotools (LAB) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 17 years of Cash from Financing Activities data on file, last reported at -$40000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$40000.0, up 13.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $576000.0 (up 100.69% YoY), and the FY2025 annual result was $570000.0, up 100.56% from the prior year.
- Cash from Financing Activities eased to -$40000.0 in Q1 2026 per LAB's latest filing, from $620000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $213.0 million in Q2 2022 and troughed at -$54.5 million in Q4 2024.
- A 5-year average of $7.2 million and a median of -$112000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities surged 18474.29% in 2022, then plunged 23180.0% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$270000.0 in 2022, then tumbled by 271.48% to -$1.0 million in 2023, then slumped by 5335.69% to -$54.5 million in 2024, then jumped by 101.14% to $620000.0 in 2025, then plunged by 106.45% to -$40000.0 in 2026.
- Business Quant data shows LAB's Cash from Financing Activities at -$40000.0 in Q1 2026, $620000.0 in Q4 2025, and -$112000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Standard Biotools | 319.06 Mn | -136.11 Mn | 11.31 Mn | -40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | 620,000.00 |
| Dec 31, 2025 | 620,000.00 |
| Sep 30, 2025 | -112,000.00 |
| Sep 30, 2025 | -112,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Dec 31, 2024 | -54.52 Mn |
| Dec 31, 2024 | -54.52 Mn |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -28.36 Mn |
| Jun 30, 2024 | -28.36 Mn |
| Mar 31, 2024 | -19.73 Mn |
| Mar 31, 2024 | -19.73 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |